Ingeborg Stalmans, Kin Sheng Lim, Francesco Oddone, Marek Fichtl, Jose I Belda, Anton Hommer, Guna Laganovska, Cédric Schweitzer, Bogomil Voykov, Tomasz Zarnowski, Gábor Holló
UNLABELLED: PURPOSE : To compare the efficacy and safety of the fixed-dose combination (FDC) of netarsudil 0.02%/latanoprost 0.005% ophthalmic solution (NET/LAT; Roclanda® ) with bimatoprost 0.03%/timolol maleate 0.5% (BIM/TIM; Ganfort® ) ophthalmic solution in the treatment of open-angle glaucoma (OAG) and ocular hypertension (OHT). METHODS: MERCURY-3 was a 6-month prospective, double-masked, randomized, multicenter, active-controlled, parallel-group, non-inferiority study...
August 24, 2023: Graefe's Archive for Clinical and Experimental Ophthalmology